SE9802264D0 - A method of isolating cells - Google Patents

A method of isolating cells

Info

Publication number
SE9802264D0
SE9802264D0 SE9802264A SE9802264A SE9802264D0 SE 9802264 D0 SE9802264 D0 SE 9802264D0 SE 9802264 A SE9802264 A SE 9802264A SE 9802264 A SE9802264 A SE 9802264A SE 9802264 D0 SE9802264 D0 SE 9802264D0
Authority
SE
Sweden
Prior art keywords
notch
ependymal
cell
relates
surface protein
Prior art date
Application number
SE9802264A
Other languages
English (en)
Swedish (sv)
Inventor
Jonas Frisen
Ann Marie Janson
Clas Johansson
Stefan Momma
Diana Clarke
Ming Zhao
Urban Lendahl
Kioumars Delfani
Johan Holmberg
Original Assignee
Neuronova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuronova Ab filed Critical Neuronova Ab
Priority to SE9802264A priority Critical patent/SE9802264D0/xx
Publication of SE9802264D0 publication Critical patent/SE9802264D0/xx
Priority to BR9911509-3A priority patent/BR9911509A/pt
Priority to KR1020007014792A priority patent/KR20010071601A/ko
Priority to EP99933396A priority patent/EP1090105B1/fr
Priority to PCT/SE1999/001157 priority patent/WO1999067363A1/fr
Priority to JP2000556008A priority patent/JP2002518043A/ja
Priority to CA002330175A priority patent/CA2330175A1/fr
Priority to CNB998078697A priority patent/CN1325637C/zh
Priority to AT99933396T priority patent/ATE293160T1/de
Priority to AU49459/99A priority patent/AU770501B2/en
Priority to MXPA00012078A priority patent/MXPA00012078A/es
Priority to ES99933396T priority patent/ES2241297T3/es
Priority to DE69924728T priority patent/DE69924728T2/de
Priority to US10/183,728 priority patent/US7320872B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9802264A 1998-06-25 1998-06-25 A method of isolating cells SE9802264D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9802264A SE9802264D0 (sv) 1998-06-25 1998-06-25 A method of isolating cells
DE69924728T DE69924728T2 (de) 1998-06-25 1999-06-24 Nicht-embryonale ependymale neuronale stammzellen und methoden zu ihrer isolierung
CA002330175A CA2330175A1 (fr) 1998-06-25 1999-06-24 Cellules embryonnaires neuronales ependymaires et methode servant a isoler celles-ci
KR1020007014792A KR20010071601A (ko) 1998-06-25 1999-06-24 뇌실막 신경 간세포 및 이의 분리 방법
EP99933396A EP1090105B1 (fr) 1998-06-25 1999-06-24 Cellules souches non-embryonnaires neuronales ependymaires et methode servant a isoler celles-ci
PCT/SE1999/001157 WO1999067363A1 (fr) 1998-06-25 1999-06-24 Cellules embryonnaires neuronales ependymaires et methode servant a isoler celles-ci
JP2000556008A JP2002518043A (ja) 1998-06-25 1999-06-24 上衣神経幹細胞とその分離方法
BR9911509-3A BR9911509A (pt) 1998-06-25 1999-06-24 Células tronco neurais ependimárias e processo para seu isolamento
CNB998078697A CN1325637C (zh) 1998-06-25 1999-06-24 室管膜神经干细胞及其分离方法
AT99933396T ATE293160T1 (de) 1998-06-25 1999-06-24 Nicht-embryonale ependymale neuronale stammzellen und methoden zu ihrer isolierung
AU49459/99A AU770501B2 (en) 1998-06-25 1999-06-24 Ependymal neural stem cells and method for their isolation
MXPA00012078A MXPA00012078A (es) 1998-06-25 1999-06-24 Celulas ependimarias del tallo neural y metodo para su aislamiento.
ES99933396T ES2241297T3 (es) 1998-06-25 1999-06-24 Celulas madre no embrionarias neuronales ependinales y metodo que sirvve para aislar estas.
US10/183,728 US7320872B2 (en) 1998-06-25 2002-06-27 Ependymal neural stem cells and method for their isolation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9802264A SE9802264D0 (sv) 1998-06-25 1998-06-25 A method of isolating cells

Publications (1)

Publication Number Publication Date
SE9802264D0 true SE9802264D0 (sv) 1998-06-25

Family

ID=20411839

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9802264A SE9802264D0 (sv) 1998-06-25 1998-06-25 A method of isolating cells

Country Status (14)

Country Link
US (1) US7320872B2 (fr)
EP (1) EP1090105B1 (fr)
JP (1) JP2002518043A (fr)
KR (1) KR20010071601A (fr)
CN (1) CN1325637C (fr)
AT (1) ATE293160T1 (fr)
AU (1) AU770501B2 (fr)
BR (1) BR9911509A (fr)
CA (1) CA2330175A1 (fr)
DE (1) DE69924728T2 (fr)
ES (1) ES2241297T3 (fr)
MX (1) MXPA00012078A (fr)
SE (1) SE9802264D0 (fr)
WO (1) WO1999067363A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541247B1 (en) * 1998-06-25 2003-04-01 Neuronova Ab Method of isolating ependymal neural stem cells
DE60123937T2 (de) * 2000-04-13 2007-06-14 The Board of Regents, The University of Texas System, Austin Behandlung von neuro-degenerativen gastrointestinalkrankheiten durch impantation von neuronalen stammzellen und/oder deren nachkommen in gastrointestinalorgane
GB0013260D0 (en) * 2000-05-31 2000-07-19 Neuronova Ab Method
AU2002307455A1 (en) * 2001-04-20 2002-11-05 Memorial Sloan-Kettering Cancer Center Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use
AU2003265094A1 (en) * 2002-08-26 2004-03-11 Neuronova Ab Method for culturing stem cells
EP1827108B1 (fr) * 2004-11-29 2015-04-08 Yeda Research And Development Co., Ltd. Induction de neurogenese et therapie par cellules souches en combinaison avec le copolymere 1
US20100015615A1 (en) * 2008-04-30 2010-01-21 Sloan-Kettering Institute For Cancer Research Identification and Isolation of Adult Stem Cells and Related Methods of Use
US8962314B2 (en) 2008-11-26 2015-02-24 The Regents Of The University Of California Lateral ventricle cell compositions and use for treating neural degenerative diseases
AU2010276201B2 (en) * 2009-07-21 2013-10-17 Abt Holding Company Use of stem cells to reduce leukocyte extravasation
ES2402308B2 (es) * 2011-09-27 2013-12-27 Universidad De Málaga Procedimiento de obtención de un cultivo puro de células ependimarias multiciliadas.
WO2019165306A1 (fr) * 2018-02-23 2019-08-29 Regeneration Biomedical, Inc. Procédés, appareils et systèmes d'instillation de cellules souches et de produits pharmaceutiques dans le système ventriculaire humain
CN111440768B (zh) * 2020-04-23 2022-09-02 青岛海尔生物科技有限公司 重组人Notch1蛋白在制备神经干细胞及皮层神经元中的应用
CN113777296A (zh) * 2021-09-16 2021-12-10 复旦大学附属中山医院 一种全量组织免疫荧光方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
EP0658194A1 (fr) * 1992-07-27 1995-06-21 California Institute Of Technology Cellules souches neurales pluripotentes de mammifere
DK0728194T3 (da) * 1993-11-09 2003-04-22 Neurospheres Holdings Ltd In situ modifikation og manipulation af stamceller fra centralnervesystemet.
CN1161744A (zh) * 1994-09-23 1997-10-08 纽罗斯菲里斯控股有限公司 中枢神经系统(cns)功能和机能障碍的体外模型
US5753505A (en) * 1995-07-06 1998-05-19 Emory University Neuronal progenitor cells and uses thereof
US5800812A (en) 1995-09-15 1998-09-01 Yeda Research And Development Co. Ltd. Methods of use of mononuclear phagocytes to promote axonal regeneration
US5780300A (en) * 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
US5753506A (en) * 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
US6093531A (en) * 1997-09-29 2000-07-25 Neurospheres Holdings Ltd. Generation of hematopoietic cells from multipotent neural stem cells
US6541247B1 (en) 1998-06-25 2003-04-01 Neuronova Ab Method of isolating ependymal neural stem cells

Also Published As

Publication number Publication date
MXPA00012078A (es) 2005-06-20
KR20010071601A (ko) 2001-07-28
ATE293160T1 (de) 2005-04-15
BR9911509A (pt) 2001-03-20
CA2330175A1 (fr) 1999-12-29
EP1090105A1 (fr) 2001-04-11
AU4945999A (en) 2000-01-10
DE69924728T2 (de) 2006-03-09
WO1999067363A9 (fr) 2000-03-16
EP1090105B1 (fr) 2005-04-13
WO1999067363A1 (fr) 1999-12-29
CN1325637C (zh) 2007-07-11
AU770501B2 (en) 2004-02-26
US7320872B2 (en) 2008-01-22
ES2241297T3 (es) 2005-10-16
US20030092176A1 (en) 2003-05-15
DE69924728D1 (de) 2005-05-19
CN1307632A (zh) 2001-08-08
JP2002518043A (ja) 2002-06-25

Similar Documents

Publication Publication Date Title
SE9802264D0 (sv) A method of isolating cells
EP1131333A4 (fr) Molecules d'acide nucleique isolees codant pour des facteurs inductibles derives de lymphocytes t (tif), proteines codees et leur utilisation
WO2000004389A3 (fr) Groupements d'agents d'interception de proteine et procedes d'utilisation de ceux-ci
WO1999061601A3 (fr) Vecteurs d'aav5 et leurs utilisation
CA2332775A1 (fr) Appareil et procede d'electrophorese
CY1111006T1 (el) Εκριμματαση ασθενειας alzheimer
CA2262920A1 (fr) Procede servant a identifier des composes exercant un effet sur les interactions de proteines de fixation d'arn et d'adn
WO1998011244A3 (fr) Vecteur de vaa4 et ses utilisations
DE59708130D1 (de) Lipidverbindungen
EP0845032A3 (fr) Molecules d'acide nucleique isolees, peptides formant des complexes avec la molecule du complexe majeur d'histocompatibilite (mhc) hla-a2 et leurs applications
EP1273918A3 (fr) Procédé de sélection des partenaires de liaison évolués à l'aide d'un épitope natif
ATE532533T1 (de) Von antikörpern abgeleitete vektoren für den transfer von substanzen in zellen
WO2005007675A3 (fr) Acides amino triazole-$g(e)
ES2185074T3 (es) Semicelula electroquimica.
WO2001004282A3 (fr) Vecteurs anti-cancereux de replication
CA2306449A1 (fr) Generation rapide de lignees cellulaires mammiferes stables produisant des niveaux eleves de proteines recombinantes
WO2000009677A3 (fr) Protease de site 1 regulee par des sterols et dosages de ses modulateurs
ATE173014T1 (de) Afamin: ein menschliches serum albumin ähnliches protein
WO1998057983A3 (fr) Proteine de mammifere de type facteur de croissance nerveuse
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
FR2755144B1 (fr) Fragments d'anticorps a chaine unique anti-p53 et utilisation
EP0899541A3 (fr) Appareil pour déterminer l'épaisseur d'un échantillon optique
WO2001064837A3 (fr) NETRINE β ET SES UTILISATIONS
AU5901199A (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
EP1342729A3 (fr) Anticorps et molécules antisense pour récepteur couplé à la protéine G avec affinité sélective pour l'ATP